aod9604 weight loss evidence clinical trials AOD 9604 Peptide for Loss: Weight and Vitality: Medical Weight Loss Obesity Clinical Trials in Utah

In experimental studies, AOD-9604 has been observed to stimulate fat oxidation , increase energy expenditure , and reduce adipose tissue accumulation through activation of beta-adrenergic lipolytic pathways

Osteoporosis High blood concentrations of homocysteine may affect bone remodeling by increasing bone resorption (breakdown), decreasing bone formation, and reducing bone blood flow

In fact, its been found that B12 supplements taken orally are just as effective as intramuscular shots in overcoming states of deficiency when you take up to 1,000 micrograms a day

Regulatory: not FDA-approved for any use, not on any FDA bulk-compounding list